A detailed history of Column Group LLC transactions in Surrozen, Inc. stock. As of the latest transaction made, Column Group LLC holds 616,540 shares of SRZN stock, worth $6.3 Million. This represents 6.04% of its overall portfolio holdings.

Number of Shares
616,540
Previous 627,651 1.77%
Holding current value
$6.3 Million
Previous $5.9 Million 64.18%
% of portfolio
6.04%
Previous 3.9%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$7.6 - $15.71 $84,443 - $174,553
-11,111 Reduced 1.77%
616,540 $9.69 Million
Q4 2023

Feb 09, 2024

SELL
$0.33 - $9.4 $2.9 Million - $82.6 Million
-8,787,144 Reduced 93.33%
627,651 $5.9 Million
Q2 2023

Jul 24, 2023

BUY
$0.55 - $0.72 $91,666 - $119,999
166,666 Added 1.8%
9,414,795 $5.18 Million
Q1 2023

May 15, 2023

SELL
$0.56 - $1.32 $93,332 - $219,999
-166,666 Reduced 1.77%
9,248,129 $5.55 Million
Q4 2022

Feb 13, 2023

BUY
$0.42 - $2.01 $69,999 - $334,998
166,666 Added 1.8%
9,414,795 $5.46 Million
Q2 2022

Aug 12, 2022

SELL
$2.14 - $3.43 $356,665 - $571,664
-166,666 Reduced 1.77%
9,248,129 $27.7 Million
Q4 2021

Feb 11, 2022

BUY
$6.0 - $9.92 $999,996 - $1.65 Million
166,666 Added 1.8%
9,414,795 $60.6 Million
Q3 2021

Nov 12, 2021

BUY
$6.98 - $12.03 $64.6 Million - $111 Million
9,248,129 New
9,248,129 $65.5 Million

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $359M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Column Group LLC Portfolio

Follow Column Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Group LLC with notifications on news.